Suggested Level of Knowlege: Detailed
LOs
BT_GS 1.39 Describe the reversal of neuromuscular blockade using anti- cholinesterase agents, anticholinergics and sugammadex and the physiological effects of reversal
BT_GS 1.56 Describe the clinical features and management of inadequate reversal of neuromuscular blockade
Past SAQs
2015.2 Compare and contrast the pharmacology of neostigmine and sugammadex.
2015.1 Discuss factors influencing the recovery and reversal of neuromuscular blockade induced by rocuronium.
2012.1 Discuss factors influencing the recovery and reversal of neuromuscular blockade induced by rocuronium.
2009.1 Outline the factors that determine the rate of recovery from non-depolarising neuromuscular block.
2006.1 Explain the possible mechanisms for prolonged neuromuscular blockade after a four hour procedure using a non-depolarising muscle relaxant.
Muscle Relaxant Reversal